Hyaluronan (HA) is an important structural element in the vitreous humor of the eye, synovial fluid, and skin of vertebrates. Moreover, HA interacts with proteins such as CD44, RHAMM, and fibrinogen, thereby influencing many natural processes such as angiogenesis, cancer, cell motility, wound healing, and cell adhesion. Reflecting such a variety of functions, HA has attracted attention from a wide range of application fields such as medicine (including surgery), cosmetics, and health foods. Traditionally HA was extracted from rooster combs, but nowadays is produced by the fermentation of streptococci. At present, quality issues such as purity and molecular weight distribution, rather than quantity, have been the focus of strain and process development in HA production. To meet ever-increasing public demand, novel systems that can yield sufficient amounts of high-quality of HA and related materials are required.
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In 1943, Meyer and Palmer isolated a novel glycosaminoglycan from the vitreous body of bovine eyes that was composed of a uronic acid and an amino sugar but no sulfoesters (1) . They proposed the name for the substance hyaluronic acid for the substance, a word derived from hyaloid (vitreous) + uronic acid. Today, this macromolecule is most frequently referred to as hyaluronan (HA), and has become one of nature's most versatile and fascinating materials. HA is a simple linear polysaccharide chain composed of alternating b-1,4-glucuronic acid (GlcA) and b-1,3-N-acetylglucosamine (GlcNAc) moieties (2) . HA occurring in all vertebrates is a major constituent of the extracellular matrices. In animals, in addition to the vitreous body of the eye where it was first found, HA is abundant in the synovial fluid of articular joints and the intercellular space of the epidermis (3) . HA involvement has been implicated in biological processes such as cell adhesion, migration and proliferation. One important function of HA is its ability to immobilize certain molecules in the desired location of the body (aggrecan, versican, neurocan, brevican, CD44, and RHAMM). In the joints, hyaluronan probably has an important role as a lubricant between the joint surfaces. It also helps the cells to detach from the matrix making it easier for them to divide. HA is reported to be involved in various events during morphogenesis and differentiation. The embryo is covered by a thick HA coating during certain stages of development. Many other biological functions of HA are believed to exist, although the details are unclear. Traditionally, it was thought to be associated with the extracellular matrix, but HA may also have other unknown roles inside the cell (4) .
Chitin is a polymer of b-1,4-linked GlcNAc that occurs in the exoskeleton of arthropods, in the cell wall of fungi, and in various components of diverse invertebrates. In addition to the structural facet of chitin polymers, chitin oligosaccharides function as important signals in the developmental processes of plants; for example, as elicitors for defense responses and as nodulation inducers for leguminous plants. The chemical structures of HA and chitin are compared in Fig. 1 .
Reflecting their wide variety of biological functions, the applications of HA as well as chitin and chitooligosaccharides extend into various fields such as medicine (including surgery), cosmetics, health food, etc. To meet ever-increasing public demand, novel systems that can afford sufficient amounts of high-quality materials are required. In this review, we describe the recent progress made in the characterization of HA synthases and HA producing processes and propose a novel system using Chlorovirus that can produce both HA and chitin.
I. HA SYNTHASES AND THEIR PROPERTIES
HA is synthesized at the inner face of the plasma membrane as a free linear polymer, in contrast to the other gly-cosaminoglycans, which are synthesized by resident Golgi enzymes and covalently attached to protein cores. The enzymes for HA synthesis are HA synthases (HASs), which are integral plasma membrane glycosyltransferases that coordinately polymerize and translocate HA out of the cell into the extracellular matrix (5) . HASs have been characterized from various organisms including streptococcal bacteria, vertebrates and Chlorovirus (5) . Based on the structural similarities and enzymatic properties, the known HASs are divided into two categories, designated Class I and Class II (5). Table 1 compares the features of HASs in the two classes. The Class II HAS (from Pasteurella multocida) is remarkably different from HASs in Class I in its structure, membrane topology, and mechanism of hyaluronan synthesis. The Class I enzymes contain 6-8 transmembrane (membrane-associated) domains distributed through the protein, while the Class II HAS has a membrane attached domain near the carboxyl terminus that anchors the protein by an unknown mechanism (6). The Class I enzymes add new sugars to the reducing end of the polysaccharide chain, whereas the Class II enzyme extends at the nonreducing end. With these variations, the HASs are unusual in that these proteins have two different glycosyltransferase activities within a single protein, contradicting to the widely held belief that "one enzyme transfers one sugar". According to the latest information, mainly obtained from streptococcal HASs, a model for HAS function on the membrane can be depicted as shown in Fig. 2A . In order to make a disaccharide unit and extend the growing polymer chain, HAS must contain at least seven distinct functions. These functions include (i) UDP-GlcNAc acceptor binding, (ii) UDP-GlcA acceptor binding, (iii) HA-GlcA-UDP donor binding, (iv) HAGlcNAc-UDP donor binding, (v) HA-GlcA-UDP : UDPGlcNAc, b-1,3(HA-GlcA)transferase, (vi) HA-GlcNAc-UDP : UDP-GlcA, b-1,4(HA-GlcNAc) transferase, and (vii) HA translocation through the membrane (7). The Pendulum hypothesis was proposed by Weigel to explain how these functions coordinate to synthesize and transfer a growing HA chain (http://www.glycoforum.gr.jp/science/hyaluronan/ HA06a/HA06aE.html). Sequence analyses indicated that the primary amino acid sequence for HAS (hasA) of Streptococcus species shared some identity with other b-glucosamyltransferases, including the nodulation factor (NodC) enzyme of Rhizobium species and chitin synthase of Saccharomyces cerevisiae and other fungi. It is noteworthy that the mouse HAS1 protein has both hyaluronan synthase activity and chito-oligosaccharide synthase activity in vitro (8) . Two of the three conserved aspartate residues and the short motif QXXRW found in HAS1 are also conserved in all Class I hyaluronan synthases, cellulose synthases, and chitin synthases, and are essential for glycosyltransferase activity (8) . From this information, Lee and Spicer proposed that the higher eukaryotic HASs have evolved from chitin synthase or cellulose synthase through the addition of the b-1-3 glycosyltransferase activity to a pre-existing b-1-4 glycosyltransferase enzyme, and that the ability to synthesize hyaluronan is a comparatively recent innovation in the evolution of metazoan organisms (4) . For comparison, a model for b-1-4 glycosyltransferase or chitin synthase (CHS) action based on the Chlorovirus CHS (described below) is shown in Fig. 2B .
II. HYALURONAN PRODUCTION
HA present in all vertebrates is a major constituent of the extracellular matrices. In some cases, HA is a major constituent in the vitreous of the human eye (0.1-0.4 mg/g wet wt.) , and/or in synovial joint fluid (3-4 mg/ml). The largest amount of HA (7-8 g per average adult human, or approximately 50% of the total in the body) resides in skin tissue, where it is present in both the dermis (0.5 mg/g wet tissue) and the epidermis (about 0.1 mg/g wet tissue) (http:// glycoforum.gr.jp/science/hyaluronan/HA01/HA01E.html). Interestingly, rooster comb, a specialized piece of skin, has even higher amounts of HA (up to 7.5 mg/ml). For industrial production, HA has historically been extracted from rooster combs. However, the collection of rooster combs and the extraction and purification procedures are timeconsuming and labor intensive, making HA production very costly (3). Moreover, in animal tissues, HA is complexed with proteoglycans and often contaminated with HA degrading enzymes, making the isolation of high purity, high molecular sized HA very difficult. Recently, the risk of crossspecies viral and other agent infection has been pointed out when using animal-derived biochemicals for human therapeutics. Alternatively, HA is also produced by some pathogenic groups A and C streptococci. Bacteria that coat themselves with a thick layer of HA are able to hide from the immune systems of their host. Bacteria known to be capable of this are Streptococcus equistimilis (a pathogen in animals), S. pyogenes (a human pathogen), S. uberis (a bovine pathogen), and P. multocida (a fowl pathogen). As described above, the streptococcal HASs are Class I family members, whereas HAS of P. multocida is the only a member of Class II (5). HA is synthesized as an extracellular capsule by these bacteria. In addition to a stealth function against the host immune system (9, 10), the capsule presumably affords the bacteria a protector function against reactive oxides released by leukocytes (11) . Bacteria may also use HA to migrate through epitherial layers into tissues (12) . Thus, the HA capsule contributes in large part to the pathogenicity of these bacteria. Despite the advantage gained by pathogenic bacteria which can produce an HA capsule, only a few species of bacteria have acquired this biosynthetic ability. This may be due to some possible disadvantages such as (i) inhibition of cell wall synthesis by deprivation of the sugar precursors and (ii) consumption of too much energy for the synthesis. Fermentation of HA by streptococci To synthesize an HA capsule in streptococci, bacterial cells mobilize three different enzymes; HAS (hasA), UDP-Glc dehydrogenase (hasB) (13) , and UDP-Glc pyrophosphorylase (hasC) (14) . These three enzymes are encoded by three different genes, hasA, hasB, and hasC, respectively, all of which are arranged in an operon. UDP-Glc dehydrogenase is required to make UDP-GlcA, one of the two substrates needed for hyaluronan synthesis from UDP-Glc. UDP-Glc pyrophosphorylase is an enzyme that creates UDP-Glc from UTP and Glc-1-phosphate. The proposed biosynthetic pathway for HA in streptococci is shown in Fig. 3 . As can be seen from Fig. 3 , UDP-GlcA is formed from Glc-6-phosphate via three steps. The pathway originating from fructose-6-phosphate and consisting of four steps is involved in the synthesis of UDPGlcNAc, the other substrate for HA synthesis. A total of 4 mol ATP is consumed to reduce 1 mol HA disaccharide repeating unit; 2 mol ATP are consumed in two glucokinase reactions to provide a phosphorylated hexose precursor for each branch of the pathway, and the other 2 mol ATP are utilized to regenerate the donor UTP. Although the reaction by UDP-Glc dehydrogenase generates 2 mol NADH for each 1 mol HA synthesis, these reducing equivalent cannot be utilized for energy generation. Figure 3 also shows that the pathways supply the structural constituents of the bacterial cell wall, especially peptidoglycan, teichoic acids and various polysaccharides. These major wall components represent a significant drain on the precursor pool for HA synthesis.
Industrially, HA has been produced by fermentation of group C streptococci since the early 1980s. Various strains of streptococci, including wild-type and HA-high-produc- ing mutants, were adopted to attain high yields of HA. Currently, a concentration of 5-10 g/l culture, beyond which the high viscosity makes the fermentation not practical, is readily achieved even using the wild-type strain in batch mode (15) . Moreover, the high value of HA means that raw material costs are not a major factor. Therefore, quality factors such as purity and size distribution rather than quantity has been the focus of strain and process development in HA production (15) . Efforts have been paid to improve the quality of HA products as follows: (i) nonhemolytic and hyaluronidase-negative mutants (16), (ii) high molecular weight HA producing mutants (US patent 6090596 and US patent 6537795), (iii) chemically defined medium (17), (iv) continuous cultures to avoid contamination by cell wall proteins (18) and pathogen factors (19) , and (v) aeration control (15) . Thus, HA production by fermentation of streptococci has been improved to a great extent over several years. However, further improvements in product quality may be still required to meet ever-increasing needs in the market.
Nowadays, genetic or metabolic engineering of HA-producing organisms based on genomic information may be a novel challenge. Complete genomic sequences are now available for some streptococci, including S. pyogenes (20) , S. mutans (21), and S. agalactiae (22) . For genetic manipulation of streptococci, various advanced vectors have become available including those for insertional mutagenesis (23) and for inducible expression (24) . Further improvement in the yield and molecular weight of HA could be attained by metabolic engineering of streptococci to balance the two principal pathways supplying precursor sugar molecules (Fig. 3) and increase in ATP yield. A variety of efforts will be made along this line.
Heterologous expression of has genes and production of HA HA production in a heterologous host may be an alternative way to overcome the problems associated with improvement of the HA quality. The hasA gene encoding HAS of streptococci is the only gene required to transform a bacterial species that does not normally produce HA, such as Escherichia coli, Enterococcus faecalis or Bacillus subtilis, into an HA producer (7, 25) . However, there is an intrinsic problem: If the bacterial cells did not greatly expand their sugar-nucleotide pool, the very active HAS would synthesize HA and deplete the cell of UDP-GlcA and UDPGlcNAc. Since the latter is generally needed for cell wall synthesis, such depletion would stop the cell from growing (the situation is the same when has is overexpressed in homologous streptococci). This, in fact, occurs when streptococcal hasA is expressed in another bacterial species. To overcome this problem, one must introduce into a heterologous host cell a set of genes necessary to supply enough of the sugar precursors, and empirically hasA and hasB should be introduced at the same time. Novozyme has reported the production of HA in B. subtilis where hasA from S. equisimilis and tuaD (hasB) from B. subtilis were chromosomally integrated (Hyaluronan 2003, Cleveland, OH, USA). In spite of no benefit in terms of HA yield and molecular weight, recovery from B. subtilis is much easier because HA is not cell-associated and there is no contamination by streptococcal pathogenic factors. By using an appropriate host E. coli mutant, DeAngelis et al. were able to express the hasA of P. multocida and confer the cells with the ability to produce HA capsule in vivo (26) . The release of HA produced in a heterologous host will change the traditional HA producing systems to the latest and highest biotechnology systems that apply metabolic engineering based on the genome information.
III. NOVEL PRODUCING SYSTEMS OF HA AND CHITIN

Chlorella-virus system
Another unique system of HA synthesis was reported recently (27) (28) (29) . Chlorovirus (or Chlorella virus) PBCV-1 was found to produce fibrous materials on the cell wall of infected host (Chlorella) cells shortly after infection. The material forming a highly developed network covering the cell wall was shown to be HA on the criteria of specific interaction with HA-binding protein and degradation with hyaluronan lyase (27) . The dsDNA genome of PBCV-1 actually encodes functional HAS (30) in addition to UDP-Glc dehydrogenase and glutamine:fructose-6-phosphate amidotransferase (GFAT) (28) . GFAT forms from glutamine and fructose-6-phosphate GlcN-6-phosphate that is converted to UDP-GlcNAc, one of the substrates of HAS (Fig. 3) . The PBCV-1 HAS (cvHAS) belongs to Class I based on its amino acid sequence and predicted structure. The cvHAS protein formed in E. coli actually synthesized HA chains composed of approximately 10 4 sugars (3-6´10 6 Da) in vitro (27) . Interestingly, manganese ion maximally stimulated HA activity; in contrast, the streptococcal and mammalian HASs prefer magnesium ion. The discovery of cvHAS is noteworthy for two reasons: (i) it is generally thought that viruses normally do not encode glycosyltransferases, but rather pirate the host enzymes to create viral glycoconjugates and (ii) HA has never been described outside of higher animals and certain bacterial pathogens. The cvHAS shares approximately 50% amino acid sequence identity with the vertebrate HAS proteins, suggesting that the viral gene may have been acquired by horizontal gene transfer from a eukaryotic host. The laboratory host cells of Chlorovirus are Chlorella-like symbiotic algae isolated from protozoa such as Paramecium bursaria (31) and do not encode HAS or its related proteins. The natural history and dissemination mechanism of Chlorovirus are largely unknown and it is quite likely that the natural host is another, as yet unknown, free-living organism. HA synthesis by Chlorella-virus system In the course of chloroviral infection, the genes for HAS as well as GFAT and UDP-Glc dehydrogenase are expressed in a very early stage, hyaluronan fibers appear on the infected Chlorella surface within 30 min post infection (p.i.), and its accumulation continued at least for 4 h (29) . At the final stage of viral infection, the infected host cells were completely lysed, so HA should be harvested before cell lysis. Experimentally, approximately 0.5-1 g hyaluronan was recovered from a 1 l culture of Chlorella cells infected with Chlorovirus (JP patent 2004-283096). The yield is lower than typical ones achieved using the streptococcal fermentation (usually more than 5-10 g/l). There may be three ways to improve the yield of hyaluronan synthesis using the Chlorella-virus system: (i) modification of Chlorovirus so the host cells do not lyse and HAS synthesis continues, namely nonlytic infection, (ii) modification of the host Chlorella cells so they continue producing the polysaccharide or transformation with the viral has genes, (iii) expression of the viral genes involved in HAS synthesis in other appropriate organisms. At this moment, genetic modification of Chlorella cells is practically difficult. Unfortunately, various trials with most available techniques have not been successful thus far at achieving a reproducible transformation of Chlorella cells. Researchers at Toyobo have recently introduced the gene of cvHAS into tobacco BY-2 cells and confirmed their expression. HA was formed both in vivo and in vitro (personal communication). Compared with existing HA producing system using streptococci, Chlorovirus has systems may provide some advantageous features as follows: (i) high molecular weight HA without degrading enzymes, (ii) easier recovery from the cell surface, (iii) avoidance of pathogen factor, (iv) eco-friendly process using CO 2 and clean light energy, and (v) chemically defined medium consisting of simple inorganic salts (33) . Chitin synthesis by Chlorella-virus system Chlorovirus PBCV-1 encodes multiple enzymes involved in HA biosynthesis, suggesting some importance for the polysaccharide production in the infection cycle. However, the has gene is not always present in all chloroviruses: Graves et al. (29) found that 9 of 37 genomic DNAs from chloroviruses isolated in the United States did not hybridize with the cvHAS gene probe in Southern blot analysis. Kawasaki et al. reported that some chloroviruses have a gene for functional chitin synthase (CHS) instead of HAS and produce chitin fibers surrounding the external surface of infected Chlorella cells (33) . All chloroviruses isolated in Japan that lacked the has gene contained the chs gene. A few viruses contained both the has and chs genes and formed both HA and chitin simultaneously on the surface of the infected host cells. Chitin is also a polymer of b-1,4-linked GlcNAc that occurs in the exoskeleton of arthropods, the cell wall of fungi, and in various components of diverse invertebrates. Interestingly, several genes sharing homology with the chitin synthase gene from Rhizobium have been found in animals, birds, fish, and amphibians (34) . Therefore, like HA, chitin may act both as a structural element and as a signaling molecule.
Chitin synthesis is directly governed by chitin synthase activity. In fungi, the chitin synthase enzyme occurs as an inactive zymogen in vesicles called chitosomes, whereas in arthropods, this enzyme is membrane-bound (35) . CVK2 CHS exhibited a high degree of similarity to the CHS3-type enzymes of yeasts and fungi (34) , however, its size (516 aa) is significantly smaller than fungal enzymes (1000-1300 aa), and the sequence homology is restricted to a carboxy terminal region of those enzymes where the conserved catalytic site exists (36) . The N-terminal regions extended in fungal enzymes has been suggested to be involved in the processing and regulation of the enzyme activities (36) . The smaller size of the CVK2 CHS protein may reflect its simpler regulatory and processing mechanism as well as different localization processes in the cell. Newly synthesized chitin was efficiently secreted across the Chlorella membrane and cell wall to the extracellular matrix (Fig. 4) , suggesting that the CVK2 CHS protein may be integrated into the membrane and cell wall, where it synthesizes chitin molecules by the addition of UDP-GlcNAc and transports the insoluble material to the extracellular space (37); a model is shown in Fig. 2 . All chloroviruses along with the CVK2 studied so far contained a functional gene for GFAT that produced the sugar precursor GlcNAc-6-phosphate required for chitin synthesis (unpublished result). This makes the CVK2 chitin production more efficient and abundant. Although the gene for UDP-GlcDH that forms GlcA required for HA synthesis is also conserved in all the chloroviruses studied (unpublished results), the alternative occurrence of the chs or has gene in chloroviruses is very interesting. In a few exceptional cases, represented by CVIK1 and CVHA1 where the two genes are coexisting, both chs and has are almost equally expressed during infection (33) , and both chitin and HA are simultaneously accumulated on the cell wall of a single virus-infected cell. These results suggest that there is no functional incompatibility between the two genes or between the two gene products, namely HA and chitin. These observations are interesting from the point of view that the higher eukaryotic HAS have evolved from chitin synthsae or cellulose synthase through the addition of the b-1-3 glycosyltransferase activity to a pre-existing b-1-4 glycosyltransferase enzyme, and that the ability to synthesize HA is a comparatively recent innovation in the evolution of metazoan organisms (4) . Recently, another example of a virus chs gene was reported. It was encoded on the large dsDNA genome (336 kbp) of Ectocarpus siliculosus virus EsV-1 (38) . EsV-1 also belongs to Phycodnaviridae but is lysogenic (39), in contrast to chloroviruses which have a lytic infection cycle. There is no information about the expression and function of the EsV-1 chs gene.
Expression of CVK2 chs gene The CVK2 chs gene is expressed as early as 5-10 min p.i. and its mRNA persists until at least 3 h p.i. (33, 40) . Chitin fibers appear on the surface of the virus-infected host cell wall within 30 min p.i. and their accumulation continues for a further 4 h (Fig. 4) , giving an appearance just like HA formed by PBCV-1 (29) . Chitin fibers are loosely associated with the host cell wall matrix and can be easily released by vortexing or ultrasonication of the cell suspension. After vortexing for 4-6 min or ultrasonication (Tomy UD201) for 30-40 s, chitin fibers (0.1-1 g/l) were recovered without cell disruption (JP patent 2004-283096). To improve the productivity of chitin using the Chlorovirus chs gene, the same tactics as those for HA synthesis described above should be adopted. When a phagemid (pBluescript SK-) containing the CVK2 chs gene (33) was introduced into E. coli cells, the bacterial cells were extraordinarily elongated and sometimes reached 100-200 mm in length (Fig. 5) . These cells were intensely stained with biotin-chitin-binding protein and avidin-Cy3 conjugate (33) . Expression of CVK2 chs in yeast cells has so far not been successful.
CONCLUDING REMARKS
To attain the highest yield, highest quality, and highest safety, existing HA producing systems may be improved by applying new technology, such as systematic genetic manipulations or metabolic engineering based on the whole genome information (Fig. 6) . One of the most attractive targets for such high technology may be the Chlorella-virus system. Besides HAS and CHS, many other useful enzymes are encoded on the large genome of Chlorovirus (41) (42) (43) (44) . These enzymes serve as a good source for metabolic engineering because some seem to represent key enzymes of various pathways, which are free from regulation.
For more details on the areas of application and area and markets for HA, see the recent review by Chong et al. (15) . Updated market data for chitin/chitosan and their oligosaccharides are available from two websites: Chitin encyclopedia.com (http://www.encyclopedia.com/html/c1/chitin.asp) and Chitin, chitosan MarketResearch.com (http://www. marketresearch.com/land/product.asp). 
